| Literature DB >> 31457864 |
Farideh Jalilehvand1, Alejandra Enriquez Garcia1, Pantea Niksirat1.
Abstract
We have combined results from several spectroscopic techniques to investigate the aerobic reactions of Rh2(AcO)4 (AcO- = CH3COO-) with l-cysteine (H2Cys) and its derivatives d-penicillamine (3,3'-dimethylcysteine, H2Pen), with steric hindrance at the thiol group, and N-acetyl-l-cysteine (H2NAC), with its amino group blocked. Previous investigations have shown that antitumor active dirhodium(II) carboxylates may irreversibly inhibit enzymes containing a thiol group at or near their active sites. Also, cysteine, the only thiol-containing proteinogenic amino acid, interacts in vivo with this class of antitumor compounds, but structural information on the products of such reactions is lacking. In the present study, the reactions of Rh2(AcO)4 and H2L were carried out in aqueous solutions at the pH of mixing (acidic) and at physiological pH, using the different mole ratios 1:2, 1:4, and 1:6, which resulted in the same products in increasing yields. Electrospray ionization mass spectrometry (ESI-MS) indicates formation of dimeric [RhIII 2Pen4]2- or oligomeric {RhIII 2L4} n (L = Cys, NAC) complexes with bridging thiolate groups. Analyses of Rh K edge extended X-ray absorption fine structure (EXAFS) data reveal 3-4 Rh-S and 2-3 Rh-(N/O) bonds around six-coordinated Rh(III) ions at mean distances of 2.33 ± 0.02 and 2.09 ± 0.02 Å, respectively. In the N-acetyl-l-cysteine compound, the RhIII···RhIII distance 3.10 ± 0.02 Å obtained from the EXAFS spectrum supports trithiolate bridges between the Rh(III) ions, as was also found when using glutathione as ligand. In the cysteine and penicillamine complexes, double thiolate bridges join the Rh(III) ions, with the nonbridging Cys2- and Pen2- ligands in tridentate chelating (S,N,O) mode, which is consistent with the ΔδC = 7.3-8.4 ppm shift of the COO- signal in their carbon-13 cross polarization magic angle spinning (CPMAS) NMR spectra. For the penicillamine complex, the 2475.6 eV peak in its S K edge X-ray absorption near edge structure (XANES) spectrum shows partial oxidation, probably caused by peroxide generated from reduction of dissolved O2, of thiolato to sulfenato (S=O) groups, which were also identified by ESI-MS for all three {RhIII 2L4} n compounds.Entities:
Year: 2017 PMID: 31457864 PMCID: PMC6644637 DOI: 10.1021/acsomega.7b01090
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Structures of [RhII2(AcO)4] (1), [RhII2(AcO)2(bpy)2(CH3CN)2]2+ (2), and Its Reaction Products with Thiolates: [RhII(μ-S-C6H5S)(η1-S-C6H5S)(bpy)]2 (3′), [RhIII(μ-S,N-C6H6NS)(η1-S-C6H6NS)(bpy)]22+ (3a), and [RhIII(S,N-C6H6NS)2(bpy)]+ (3b) Reported in Refs (13−15)
Figure 1(Left) UV–vis spectroscopy of reaction progress for Rh2(AcO)4 with H2NAC (mole ratio of 1:4, C = 1.0 mM, pH of mixing = 2.8); peak positions are obtained from second derivatives. (Right) ESI-mass spectrum (+ ion mode) of the same solution measured after 48 h; see Table for peak assignments.
Assignment of the ESI-MS Peaks Shown in Figure (Right)a
| isotopic pattern | assignment | isotopic pattern | assignment | ||
|---|---|---|---|---|---|
| 186.02 | M + 1 | [H2NAC + Na+]+ | 627.88 | M + 1 | [2RhII + 4AcO– + H2NAC + Na+]+ |
| 325.05 | M + 1 | [2H2NAC – 2H+ + H+]+ | 671.08 | M + 1 | [4H2NAC – 4H+ + Na+]+ |
| 347.03 | M + 1 | [2H2NAC – 2H+ + Na+]+ | 766.91 | M + 1 | [2RhIII + 4AcO– + 2HNAC– + H+]+ |
| 459.90 | M + 1 | [2RhII + 4AcO– + NH4+]+ | 788.90 | M + 1 | [2RhIII + 4AcO– + 2HNAC– + Na+]+ |
| 464.85 | M + 1 | [2RhII + 4AcO– + Na+]+ | 810.88 | M + 1 | [2RhIII + 4AcO– + 2HNAC– – H+ +2Na+]+ |
| 505.88 | M + 1 | [2RhII + 4AcO– + CH3CN + Na+]+ |
H2NAC = C5H9NO3S; 2H2NAC – 2H+ is the oxidized form of N-acetylcysteine with an S–S bond; AcO– = CH3COO–.
Figure 2ESI-mass spectra (− ion mode) of the products (in water) obtained from the reactions of Rh2(AcO)4 with cysteine (5, top), penicillamine (6, middle), and N-acetylcysteine (7, bottom) at a mole ratio of 1:4 at pH = 7.4 (fragmentor voltage 80 V). For peak assignments, see Table .
Assignment of the Mass Ions Observed in the ESI-Mass Spectra (− Ion Mode) of Products 5–7 Shown in Figure a
| isotopic pattern | assignment | isotopic pattern | assignment | ||
|---|---|---|---|---|---|
| Rh–Cysteine Product ( | |||||
| 340.91 | M + 0.5 | [2RhIII + 4H2Cys – 8H+]2– | 511.87 | M + 0.5 | [3RhIII + 6H2Cys – 11H+]2– |
| M + 0.33 | [3RhIII + 6H2Cys – 12H+]3– | 519.87 | M + 0.5 | [3RhIII + 6H2Cys – 11H+ + O]2– | |
| 348.91 | M + 0.5 | [2RhIII + 4H2Cys – 8H+ + O]2– | 682.83 | M + 0.5 | [4RhIII + 8H2Cys – 14H+]2– |
| 356.91 | M + 0.5 | [2RhIII + 4H2Cys – 8H+ + 2O]2– | M + 1 | [2RhIII + 4H2Cys – 7H+]− | |
| 409.42 | M + 0.5 | [2RhIII + 5H2Cys – 8H+ + O]2− | 690.83 | M + 0.5 | [4RhIII + 8H2Cys – 14H+ + O]2– |
| 417.42 | M + 0.5 | [2RhIII + 5H2Cys – 8H+ + 2O]2– | 698.83 | M + 0.5 | [4RhIII + 8H2Cys – 14H+ + 2O]2– |
| 454.89 | M + 0.33 | [4RhIII + 8H2Cys – 15H+]3– | M + 1 | [2RhIII + 4H2Cys – 7H+ + O]− | |
| Rh–Penicillamine Product ( | |||||
| 339.44 | M + 0.5 | [2RhIII +3H2Pen + S2– – 6H+]2– | 794.96 | M + 0.5 | [4RhIII + 8H2Pen – 14H+]2– |
| 347.44 | M + 0.5 | [2RhIII + 3H2Pen + S2– – 6H+ + O]2– | M + 1 | [2RhIII + 4H2Pen – 7H+]− | |
| 355.44 | M + 0.5 | [2RhIII + 3H2Pen + S2– – 6H+ + 2O]2– | 810.95 | M + 0.5 | [4RhIII + 8H2Pen – 14H+ + O]2– |
| 396.98 | M + 0.5 | [2RhIII + 4H2Pen – 8H+]2– | M + 1 | [2RhIII + 4H2Pen – 7H+ + O]− | |
| 404.97 | M + 0.5 | [2RhIII + 4H2Pen – 8H+ + O]2– | 816.94 | M + 1 | [2RhIII + 4H2Pen – 8H+ + Na+]− |
| 412.97 | M + 0.5 | [2RhIII + 4H2Pen – 8H+ + 2O]2– | 826.95 | M + 1 | [2RhIII + 4H2Pen – 7H+ + 2O]− |
| Rh– | |||||
| 323.04 | M + 1 | [2H2NAC – 3H+]− | 637.91 | M + 0.5 | [3RhIII + 6H2NAC – 11H+]2– |
| 344.43 | M + 0.5 | [2RhII + 3H2NAC – 6H+]2– | M + 0.25 | [6RhIII + 12H2NAC – 22H+]4– | |
| 424.93 | M + 0.5 | [2RhIII + 4H2NAC – 8H+]2– | 648.90 | M + 0.5 | [3RhIII + 6H2NAC – 12H+ + Na+]2– |
| M + 0.33 | [3RhIII + 6H2NAC – 12H+]3– | M + 0.25 | [6RhIII + 12H2NAC – 24H+ + 2Na+]4– | ||
| 432.93 | M + 0.5 | [2RhIII + 4H2NAC – 8H+ + O]2– | 850.87 | M + 1 | [2RhIII + 4H2NAC – 7H+]− |
| 506.45 | M + 0.25 | [2RhIII + 5H2NAC – 10H+]4– | M + 0.5 | [4RhIII + 8H2NAC – 14H+]2– | |
| 512.57 | M + 0.33 | [4RhIII + 7H2NAC – 15H+]3– | M + 0.33 | [6RhIII + 12H2NAC – 21H+]3– | |
| 556.39 | M + 0.5 | [3RhIII + 5H2NAC – 11H+]2– | 861.87 | M + 0.5 | [4RhIII + 8H2NAC – 15H+ + Na+]2– |
| M + 0.25 | [6RhIII + 10H2NAC – 22H+]4– | 872.86 | M + 1 | [2RhIII + 4H2NAC – 8H+ + Na+]− | |
| 566.92 | M + 0.33 | [4RhIII + 8H2NAC – 15H+]3– | M + 0.5 | [4RhIII + 8H2NAC – 16H+ + 2Na+]2– | |
| 621.26 | M + 0.33 | [4RhIII + 9H2NAC – 15H+]3– | M + 0.33 | [6RhIII + 12H2NAC −24H+ + 3Na+]3– | |
H2Cys = C3H7NO2S; H2Pen = C5H11NO2S; H2NAC = C5H9NO3S; 2H2NAC – 2H+ is the oxidized form of N-acetylcysteine with a S–S bond.
Figure 3Sulfur K edge XANES spectra (left) and the corresponding smoothed second derivatives (right) of the solid products obtained from the reactions of Rh2(AcO)4 with cysteine (5), penicillamine (6), or N-acetylcysteine (7) at a mole ratio of 1:4 at pH = 7.4.
Figure 4k3-Weighted Rh K edge EXAFS spectra (left) and the corresponding Fourier transforms (right) of the solid products obtained from the reactions of Rh2(AcO)4 with cysteine (5), penicillamine (6), and N-acetylcysteine (7) at a mole ratio of 1:4 at pH = 7.4, compared to those of a concentrated solution of the dinuclear Rh-glutathione reaction product (8) (see Table ).
Least-Squares Curve-Fitting Results for EXAFS Spectra of the Solid Reaction Products 5–7 and a Concentrated Solution of the Rh–Glutathione Reaction Product 8a,b
| Rh–(N/O) | Rh–S | Rh···Rh | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| sample | CN | σ2 (Å2) | CN | σ2 (Å2) | CN | σ2 (Å2) | Δ | ||||
| 2.0 | 2.10 | 0.0037 | 4.1 | 2.34 | 0.0044 | 2.0 | 3.44 | 0.0142 | 0.7 | 14.7 | |
| 3.2 | 2.10 | 0.0039 | 3.2 | 2.315 | 0.0042 | 0.77 | 3.03 | 0.0078 | –0.4 | 18.5 | |
| 2 | 2.09 | 0.0032 | 4.6 | 2.32 | 0.0050 | 0.80 | 3.10 | 0.0047 | –0.2 | 17.5 | |
| 2.5 | 2.08 | 0.0034 | 4.1 | 2.33 | 0.0050 | 0.85 | 3.11 | 0.0046 | 1.2 | 17.6 | |
See Figure .
Amplitude reduction factor (S02) = 0.92 fixed;[23]f = fixed value; estimated errors: R ± 0.02 Å; σ2 ± 0.001 Å2; CN ± 10–15%.
Uncertain values for 5 and 6 (see text).
= fitting residual (%).
Figure 5Solid state 13C CPMAS NMR spectra obtained for Rh2(AcO)4 and its reaction products at a mole ratio of 1:4 with the ligands cysteine (4, pH = 3.2; 5, pH = 7.4), penicillamine (6), and N-acetylcysteine (7), and for the pure solid ligands.
Scheme 2Proposed Pathway for Aerobic Reaction of Rh2(AcO)4 with Penicillamine: (a) [RhII2(AcO)4(H2Pen)], (b) [RhIII2(AcO)4(HPen)2], (c) H2[RhIII(Pen)4], and Its Oxidized Form (d) H2[Rh2(Pen)2(Pen(SO))2], All Detected by ESI-MS at Acidic pH
The reactions occur much faster at pH = 7.4, leading to compound 6, Na2[Rh2(Pen)2(Pen(SO))2]·4.5H2O, with a structure similar to (d).
Scheme 3Proposed Structures for a Tetrameric {Na2[Rh2(Cys)4]}2 Complex in Compound 5
The lower image is its oxidized form, detected by ESI-MS, with sulfenato (S=O) groups.
Scheme 4Proposed Oligomeric Structures for the {Na2[Rh2(NAC)4]·4.5H2O} (Compound 7)